To read the full article sign up for free or sign in.

Real-world study shows COVID-19 vaccines reduce serious disease in elderly

March 3, 2021

LONDON – A further U.K. real-world study of COVID-19 vaccines has found a single dose dramatically reduces the chances of the most elderly and frail being admitted to the hospital as a result of serious infection.

BioWorld Coronavirus Vaccine Europe

Free access to BioWorld coronavirus articles

BioWorld

The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

Novavax vaccine shows its chops

BioWorld

Given that Novavax Inc.’s COVID-19 vaccine will be a latecomer to the U.S. scene if it gets FDA authorization, it’s been cast in a supporting role to the lead...

Today's news in brief

BioWorld MedTech

BioWorld MedTech's briefs for July 1.

Biomarin outlines pricing strategy for costly hemophilia A gene therapy after backing from European regulators

BioWorld

The first gene therapy to treat severe hemophilia A was among the drugs recommended for European approval by regulators from the EMA’s CHMP at its monthly...

Bluebird’s eli-cel gene therapy for CALD snatches adcom victory from jaws of defeat

BioWorld

The Cellular, Tissue and Gene Therapies Advisory Committee scrutinized Bluebird Bio Inc.’s gene therapy elivaldogene autotemcel (eli-cel) for early active...

Upgrade your daily dose of biopharma and medtech news

Real-world study shows COVID-19 vaccines reduce serious disease in elderly